What’s the Difference Between Hepatitis A, B and C?
Understand the types of hepatitis and learn how to protect yourself
Chronic Illness, Hepatitis A, Hepatitis B, Hepatitis C, Hepatology, Liver Disease
Category: Hepatitis C
UNC a lead site in clinical trial of three hepatitis C medications
Dr. Michael Fried, director of the UNC Liver Center, is a co-principal investigator of the PRIORITIZE Study.
UNC researchers discover how Hepatitis C virus persists for years
Hepatitis C virus (HCV) lingers in the human body for years, slowly damaging the liver and leading to liver diseases such as hepatitis, cirrhosis and liver cancer, which is often fatal. Research conducted at the University of North Carolina at Chapel Hill has discovered a mechanism that facilitates the virus achieving this life-long persistence. Chronic HCV infection is the leading cause of liver cancer in the United States.
FDA, academia and industry team up to end hepatitis C
The Hepatitis C Therapeutic Registry and Research Network, or HCV-TARGET, is led jointly by investigators at the University of North Carolina School of Medicine and University of Florida and is sponsored in part by multiple pharmaceutical companies.
UNC researchers discover how hepatitis C virus reprograms human liv...
Researchers in the laboratory of Stanley M. Lemon, MD, outline the critical role the microRNA known as miR-122 plays in the life cycle of the hepatitis C virus.
Milk thistle, taken by many people for liver disease, ineffective a...
Silymarin or “milk thistle,” a popular herbal dietary supplement that many people take for liver ailments, works no better than placebo in patients with chronic hepatitis C infection.
Chronic Illness, Clinical Trials, Hepatitis C, Hepatology, Nutrition, Treatment, Wellness
Hepatitis C virus hijacks liver microRNA
Mechanism explains how virus survives in the liver and how a new antiviral works.
24-week hepatitis C treatment as effective as 48-week treatment
A new study, conducted in part at UNC, finds that a 24-week triple medication treatment course for hepatitis C is just as effective as a 48-week regimen.